AI-powered remote patient monitoring and virtual care delivery platform
Biofourmis operates a real-time biomarker monitoring and clinical decision-support platform built on AWS and Kubernetes infrastructure. The tech stack reveals a DevOps-heavy engineering focus—CDK, Jenkins, ArgoCD, and WAF indicate mature CI/CD and infrastructure-as-code practices—while concurrent projects in disaster recovery, multi-site deployments, and medication algorithms signal scaling pressure across both platform reliability and clinical product lines. Hiring velocity is decelerating with only one role posted in the last 30 days, despite active work on telemedicine growth and chronic care programs.
Biofourmis delivers AI-driven remote patient monitoring and virtual care services to health systems, payers, and biopharma companies. The platform collects and analyzes biomarkers in real time to identify clinical deterioration and trigger proactive interventions, enabling hospital-level care delivery outside traditional clinical settings. The company operates globally from headquarters in Needham, Massachusetts, with key offices in Singapore and India, and serves use cases spanning post-acute monitoring, remote clinical trials, oncology, and cardiovascular care. Active projects include infrastructure automation on Kubernetes, chronic care program scaling, telemedicine expansion, and medication management algorithms—reflecting operational complexity in multi-site enterprise deployments and clinical integration.
Biofourmis runs on AWS (including CDK, WAF, KMS, Secrets Manager), Kubernetes, Jenkins, ArgoCD, and integrates with Epic Systems and Cerner EHR platforms.
Biofourmis is headquartered in Needham, Massachusetts, with key offices in Singapore and India.
Active projects include infrastructure-as-code on Kubernetes, CI/CD pipeline development, disaster recovery frameworks, telemedicine program scaling, medication management algorithms, and multi-site enterprise deployments.
Other companies in the same industry, closest in size